Feitosa, Mateus Paiva Marques
Lima, Eduardo Gomes
Abizaid, Alexandre Antônio Cunha
Mehran, Roxana
Lopes, Neuza Helena Moreira
de Assis Fischer Ramos, Thiago
Hideo-Kajita, Alexandre
Filho, Roberto Kalil
Junior, Carlos Vicente Serrano
Clinical trials referenced in this document:
Documents that mention this clinical trial
The safety of SGLT-2 inhibitors in diabetic patients submitted to elective percutaneous coronary intervention regarding kidney function: SAFE-PCI pilot study
https://0-doi-org.brum.beds.ac.uk/10.1186/s13098-023-01107-9
Article History
Received: 18 April 2023
Accepted: 8 June 2023
First Online: 26 June 2023
Declarations
:
: This study was approved by the institutional review board of the Instituto do Coracao (InCor) of the Faculty of Medicine of the University of Sao Paulo and the need for informed consent was obtained as part of the study approval.
: Not applicable.
: The authors declare that they have no competing interests.